Study of Blood Samples From Newborns With Down Syndrome
Trial ID or NCT#
NCT00959283
Status
NOT RECRUITING
Purpose
This research study is looking at blood samples from newborns with Down syndrome. Studying the genes expressed in samples of blood from patients with Down syndrome may help doctors identify biomarkers related to cancer.
Official Title
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Eligibility Criteria
Ages Eligible for Study: Younger than 90 Days
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Investigator(s)
Neyssa Marina
Contact us to find out if this trial is right for you.
Contact
CCTO
650-498-7061
View on ClinicalTrials.gov
